Venture Accelerator
Below is a list of select startups that are tenants in the Venture Accelerator utilizing the expertise and full suite of business services of Tech Transfer’s Venture Center.
Arborsense
Transdermal bio sensors for monitoring alcohol and drug use
Cartox
In vitro cardiotoxicity testing platform using mature human stem cell derived cardiomyocytes
CubeWorks
CubeWorks is accelerating the future of IoT through millimeter-scale smart sensing solutions. CubeWorks leads revolutionary advances in ultra-low power computing through its CubiSens™ Platform, the world’s smallest wireless smart sensors, unmatched in longevity, intelligence, accuracy, value, and ease of use.
Elegus
Elegus is commercializing an aramid-based, ultra-strong battery separator made from high-performance nano-scale fibers. We believe our separator is thin and strong enough to enable lithium-ion batteries to increase energy density without compromising safety
Endectra
Endectra LLC is commercializing solid-state, real-time radiation detection technology to displace expensive crystal- and gas-based sensors in defense, industrial, and medical applications.
G-HMRC
The G-HMRC will provide health risk assessment (HRA) services and products as a multi-channel intelligent communication tool for health management decision support and will continue to advance our offerings through ongoing research and technology developments.
GreenMark Biomedical
To enable oral healthcare professionals to preserve teeth through earlier diagnosis & non-invasive treatment.
InheRET
Risk evaluation tool uses your personal and family health history to find out if you are at increased risk for hereditary disease using easy-to-read report with next-step recommendations helps you and your doctor make a care plan to reduce your risk
Labyrinth Biotech Inc
Microfluidic technology for the isolation and capture of circulating tumor cells for research purposes and clinical diagnosis
Mekanistic Therapeutics
Mekanistic Therapeutics designs and discovers anti-cancer agents that inhibit multiple cancer drivers. Our lead agent, MTX-211 is a potent and selective dual inhibitor of two frequently aberrant cancer drivers. It is effective against a number of cancer types generally resistant to monotherapy alone.
MemryX
Designs neural network inference chips with unparalleled energy efficiency and compute density for edge computing, IoT, mobile, and more
Omniscent
Handheld MEMS-based VOC sensor system capable of detecting 20 VOC gases simultaneously
Opsidio, LLC
Therapeutic monoclonal antibody for pulmonary fibrosis/asthma/fibrotic lung disease
Phenomics Heatlh
Precision clinical treatment support products and services based on advanced pharmacoepigenomics
Phrixus Pharmaceuticals, Inc.
Treatment for symptoms of DMD and heart failure